Search results
Author(s):
Shunsuke Kiuchi
,
Shinji Hisatake
,
Yoshiki Murakami
,
et al
Added:
1 year ago
Author(s):
Sara Saberi
Added:
5 months ago
Master the diagnostic complexities of hypertrophic cardiomyopathy (HCM) with Dr Sara Saberi, a leading expert in inherited cardiovascular diseases.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into the nuanced approach required for accurate HCM diagnosis and risk stratification.Dr Saberi…
View more
Jonathan Byrne
Research Area(s) / Expertise:
Job title: PhD, MB, ChB
Author
Cardiac Troponins in Kidney Disease
Author(s):
Daniel Murphy
,
Debasish Banerjee
Added:
6 months ago
Review Article
Author(s):
Marc Dweck
Added:
1 year ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;…
View more
ECG in Severe COVID-19 Infection
Author(s):
Kapil Rajendran
,
Baiju Rajan
,
Sivaprasad Kunjukrishnapilla
,
et al
Added:
1 year ago
Short Communication
Left Atrium Role in Secondary Mitral Regurgitation
Author(s):
Markos Koukos
,
Yannis Dimitroglou
,
Dimitrios Tsartsalis
,
et al
Added:
1 year ago
Review Article
Author(s):
Evald Høj Christiansen
Added:
4 months ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA…
View more
Author(s):
Frédéric Sacher
Added:
10 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9…
View more
Henry J Dargie
Job title: Consultant Cardiologist
Author